Dexmedetomidine for Catheter-related Bladder Discomfort

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 114 participants.

Also called NCT01991223

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 114 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01991223
Other papers using this trial's data
  • The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: A double-blind randomised study European journal of anaesthesiology, 2015-09 DOI, PubMed 25485879

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01991223. Randomized; double masking; primary purpose prevention. Start 2013-11 (registry gives no type); primary completion 2014-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dexmedetomidine for Catheter-related Bladder Discomfort
Acronym
CRBDEX
Condition
Pain
Condition
Blood Pressure
Condition
Nausea
Condition
Vomiting
Condition
Arrhythmia
Intervention (Drug)
Dex infusion
Intervention (Drug)
NS infusion
Lead sponsor
Seoul National University Hospital (class: other)

Record details

Record id
cardio:ct-nct01991223
Content hash
2832a09d22148c383dcec219aa3c600180b1d156317f7096e7ebb0d5bd44e228